Acelyrin News

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $5

Futu NewsDec 21 02:31

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Cuts Target Price to $5

Futu NewsDec 19 18:36

Hold Rating Maintained for ACELYRIN, INC. Amidst Izokibep Study Setback and Revised Sales Projections

TipRanksDec 19 18:27

ACELYRIN Is Maintained at Overweight by Wells Fargo

Dow JonesDec 11 23:15

Wells Fargo Maintains Overweight on Acelyrin, Lowers Price Target to $13

BenzingaDec 11 23:06

Piper Sandler Maintains Acelyrin(SLRN.US) With Buy Rating, Maintains Target Price $20

Futu NewsDec 11 21:31

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $6 to $20

Futu NewsDec 11 21:01

ACELYRIN, INC. (SLRN) Receives a Buy From Piper Sandler

TipRanksDec 11 19:47

HC Wainwright & Co. Reiterates Neutral on Acelyrin, Maintains $8 Price Target

BenzingaDec 11 19:24

Acelyrin Analyst Ratings

BenzingaDec 11 19:23

Hold Rating for ACELYRIN, INC. Amid Izokibep Trial Setback and Focus on Lonigutamab Development

TipRanksDec 11 18:49

Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Cabaletta Bio (CABA) and Mersana Therapeutics (MRSN)

TipRanksNov 15 18:32

Vikram Purohit's Hold Rating on ACELYRIN, INC.: Awaiting Key Data and Trial Progress for Future Stock Movement

TipRanksNov 15 18:32

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $6

Futu NewsNov 15 18:31

ACELYRIN Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesNov 15 02:42

Acelyrin Analyst Ratings

BenzingaNov 15 02:33

Piper Sandler Maintains Acelyrin(SLRN.US) With Buy Rating, Maintains Target Price $20

Futu NewsNov 14 21:34

TD Cowen Maintains Acelyrin(SLRN.US) With Buy Rating

Futu NewsNov 14 21:34

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $8 to $20

Futu NewsNov 14 21:06

Acelyrin's Phase 3 Trial Progress and Uncertainties Lead to Hold Rating

TipRanksNov 14 19:20